Prognosis of Very Low Dose SPECT



Status:Completed
Conditions:Angina
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:2/7/2015
Start Date:July 2011
End Date:November 2013
Contact:Andrew J Einstein, MD, PhD
Email:andrew.einstein@columbia.edu
Phone:212-305-6812

Use our guide to learn which trials are right for you!

Prognosis of Very Low Dose Stress First Myocardial Perfusion SPECT in Patients With Chest Pain Using an Alcyone Camera

Nuclear stress testing evaluates whether the heart receives enough blood, by injection of a
nuclear isotope during a stress on the heart that permits taking pictures of the heart
muscle. A low-radiation-dose protocol for nuclear stress testing involves injecting less of
the nuclear isotope than standard protocols, by utilizing a new, more efficient camera
(called an Alcyone camera) which could decrease radiation dose to patients while still
providing excellent clinical information. Subjects will undergo imaging under the Alcyone
camera after undergoing stress testing with exercise or a standard medication simulating
exercise, and then at rest if needed. Subjects will have follow-up to measure events
occurring after the test, such as death, heart attack, unstable angina, repeat emergency
department visit for chest pain evaluation, or repeat imaging needed to evaluation for
coronary artery disease. Radiation doses and quality of the images from the imaging with the
new protocol will be recorded to compare to those used in standard nuclear imaging
protocols. The primary study hypothesis is that greater than 90% of patients who have a
normal very low dose stress first myocardial perfusion scintigraphy (MPS) will be free at 3
months after study of death, nonfatal myocardial infarction, unstable angina, and repeat
emergency department visit for chest pain evaluation or repeat anatomical or functional
cardiac imaging.

See brief summary above.

Inclusion Criteria:

- Patients presenting with chest pain but normal or nondiagnostic electrocardiograms
and at least 3 negative troponin levels taken 4 or more hours apart.

- Age greater than 18 years.

- Written informed consent is obtained by a study investigator.

Exclusion Criteria:

- Previous Myocardial perfusion scintigraphy (MPS) with evidence of scar

- Previous MPS with evidence of ischemia and no subsequent revascularization

- Known dilated left ventricle

- Known cardiomyopathy

- High pre-test probability of a perfusion defect on MPS

- Body mass index greater than 35

- Prisoner status
We found this trial at
1
site
?
mi
from
New York, NY
Click here to add this to my saved trials